These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 19620854)
1. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation. Keck PE; Hsu HA; Papadakis K; Russo J Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854 [TBL] [Abstract][Full Text] [Related]
2. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186 [TBL] [Abstract][Full Text] [Related]
4. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
5. An open-label, flexible-dose study of memantine in major depressive disorder. Ferguson JM; Shingleton RN Clin Neuropharmacol; 2007; 30(3):136-44. PubMed ID: 17545748 [TBL] [Abstract][Full Text] [Related]
6. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. Ketter TA; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011 [TBL] [Abstract][Full Text] [Related]
8. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784 [TBL] [Abstract][Full Text] [Related]
9. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)]. Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G Encephale; 2003; 29(6):499-505. PubMed ID: 15029084 [TBL] [Abstract][Full Text] [Related]
10. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653 [TBL] [Abstract][Full Text] [Related]
13. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD; Shults J J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727 [TBL] [Abstract][Full Text] [Related]
14. Risperidone monotherapy in manic inpatients: an open label, multicentre trial. Forsthoff A; Grunze H; Seemüller F; Stampfer R; Dittmann S; Amann B; Schmidt F; Schäfer M; Hermle L; Walden J; Schreiner A World J Biol Psychiatry; 2007; 8(4):256-61. PubMed ID: 17853251 [TBL] [Abstract][Full Text] [Related]
15. Quetiapine for the treatment of bipolar mania in older adults. Sajatovic M; Calabrese JR; Mullen J Bipolar Disord; 2008 Sep; 10(6):662-71. PubMed ID: 18837860 [TBL] [Abstract][Full Text] [Related]
16. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969 [TBL] [Abstract][Full Text] [Related]
17. A pilot double-blind treatment trial of memantine for alcohol dependence. Evans SM; Levin FR; Brooks DJ; Garawi F Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918 [TBL] [Abstract][Full Text] [Related]
18. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886 [TBL] [Abstract][Full Text] [Related]
19. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM). Van Riel WG; Vieta E; Martinez-Aran A; Haro JM; Bertsch J; Reed C; Van Os J World J Biol Psychiatry; 2008; 9(4):313-20. PubMed ID: 18949649 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]